COMPASS THERAPEUTICS INC (CMPX) Stock Income Statement
NASDAQ:CMPX - Nasdaq - US20454B1044 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 850.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 57.48M | 50.36M | 41.66M | 81.88M | 27.81M | |||
| Research and Development | 42.34M | 38.12M | 30.00M | 70.96M | 14.90M | |||
| Selling, General, and Administrative Expenses | 15.13M | 12.24M | 11.66M | 10.93M | 12.91M | |||
| Operating Income | -56.63M | -50.36M | -41.66M | -81.88M | -27.81M | |||
| Interest Income/Expense | 7.30M | 7.87M | 2.36M | -340.00K | -1.38M | |||
| Other Income/Expense | -50.00K | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -49.38M | -42.49M | -39.23M | -82.18M | -29.47M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 30.00K | |||
| Net Income | -49.38M | -42.49M | -39.23M | -82.18M | -29.50M | |||
| EBITDA | -56.04M | -49.66M | -40.88M | -81.31M | -25.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.36 | -0.33 | -0.37 | -1.31 | -0.96 | |||
| Non GAAP EPS | -0.37 | -0.34 | -0.37 | N/A | N/A | |||
| Statistics | ||||||||
| Profit Margin | -5808.82% | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | -6661.76% | N/A | N/A | N/A | N/A | |||
All data in USD